dc.contributor.author | Ozkurt, E. | |
dc.contributor.author | Muslumanoglu, M. | |
dc.contributor.author | Saip, P. | |
dc.contributor.author | Cabioglu, Neslihan | |
dc.contributor.author | Tukenmez, Mustafa | |
dc.contributor.author | Trablus, D. Can | |
dc.contributor.author | Oner, G. | |
dc.contributor.author | Yavuz, E. | |
dc.contributor.author | Onder, S. | |
dc.contributor.author | Karatay, H. | |
dc.date.accessioned | 2021-03-03T07:51:33Z | |
dc.date.available | 2021-03-03T07:51:33Z | |
dc.identifier.citation | Cabioglu N., Onder S., Oner G., Karatay H., Ozkurt E., Trablus D. C. , Tukenmez M., Muslumanoglu M., Saip P., Yavuz E., "Differential expression of novel immunological biomarkers in TILS is associated with improved outcome in advanced triple negative breast cancer resistant to neoadjuvant chemotherapy", BREAST, cilt.44, 2019 | |
dc.identifier.issn | 0960-9776 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_144b2047-3fd9-45f0-b904-f0cf14acd0d3 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/19044 | |
dc.identifier.uri | https://doi.org/10.1016/s0960-9776(19)30176-6 | |
dc.language.iso | eng | |
dc.subject | Kadın Hastalıkları ve Doğum | |
dc.subject | ONKOLOJİ | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | KADIN HASTALIKLARI & DOĞUM | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Onkoloji | |
dc.subject | Cerrahi Tıp Bilimleri | |
dc.subject | Obstetrics and Gynecology | |
dc.subject | Oncology | |
dc.subject | Health Sciences | |
dc.title | Differential expression of novel immunological biomarkers in TILS is associated with improved outcome in advanced triple negative breast cancer resistant to neoadjuvant chemotherapy | |
dc.type | Makale | |
dc.relation.journal | BREAST | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 44 | |
dc.contributor.firstauthorID | 262744 | |